Stephen Gottschalk

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies

Targeting protein–ligand neosurfaces with a generalizable deep learning tool

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity

Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models